Diagnostic Imaging Radiation: How Much of a Clinical Issue?

Sunday, April 3, 8:00-9:30 AM

The issue of radiation dose associated with diagnostic imaging can be challenging to clinicians. In this session, attendees will hear from a physicist and a representative from the FDA in what promises to be an interesting view from the technical and regulatory perspective. Clinicians also will discuss risk/benefits associated with imaging with an interesting twist.

Speaker Information
  • Kevin L. Nelson, PhD, Mayo Clinic, Jacksonville, Fla. -- Diagnostic Imaging Radiation: How Much of a Clinical Issue? View of the Physicist
  • Orhan H. Suleiman, PhD, FDA's Center for Drug Evaluation and Research, Rockville, Md. -- Diagnostic Imaging Radiation Exposure: View of a Regulatory Agency
  • Rita F. Redberg, MD, University of California, San Francisco -- Assessing Risk in the Face of Benefit
  • Jack A. Ziffer, MD, PhD, Miami Cardiac and Vascular Institute, Miami -- Assessing Benefit in the Face of Risk

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.